morphosys ag (MOR:Xetra)
Earnings & Estimates Summary - MORPHOSYS AG (MOR)
2013 revenues at Morphosys AG totaled €78.0M EUR, while annual earnings equaled €0.30 per share.
Quarterly Earnings & Estimates - MORPHOSYS AG (MOR)
Morphosys AG's Quarterly Earnings
Morphosys AG reported 2nd quarter 2014 losses of €0.02 per share on 07/30/2014.
Annual Earnings & Estimates - MORPHOSYS AG (MOR)
Morphosys AG's Annual Earnings
Morphosys AG reported annual 2013 earnings of €0.30 per share on 03/2/2014.
Quarterly Revenues - MORPHOSYS AG (MOR)
Morphosys AG's Quarterly Revenues
Morphosys AG had 2nd quarter 2014 revenues of €14.6M EUR. This missed the €14.7M EUR consensus estimate of the 2 analysts following the company. This was -53.4% below the prior year's 2nd quarter results.
Annual Revenues - MORPHOSYS AG (MOR)
Morphosys AG's Annual Revenues
Morphosys AG had revenues for the full year 2013 of €78.0M EUR. This was 12.1% above the prior year's results.
|Ablynx NV||€8.34 EUR||-0.137|
|Dyax Corp||$9.94 USD||-0.17|
|Genmab A/S||kr251.30 DKK||+0.20|
|ImmunoGen Inc||$10.46 USD||+0.0099|
|Intrexon Corp||$17.50 USD||-0.17|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|